Heme binding compounds and use thereof

Details Heme binding compounds and use thereof Heme binding compounds and use thereof

1993-07-07

1995-06-13

Hollrah, Glennon H.

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

562557, 562560, 549 76, C07D33312, C07C32102, C07C22926

Patent

active

054244471

ABSTRACT:
Inhibitors of nitric oxide formation from arginine useful for treating hypotension, inflammation, stroke and to restore vascular contractile sensitivity to the effects of .alpha..sub.1 adrenergic agonists are physiologically active compounds including N.sup..delta. -substituted ornithine or N.sup..epsilon. -substituted lysine moieties or monoalkyl carbon-substituted N.sup..delta. -substituted ornithine or N.sup..epsilon. -substituted lysine moieties, having the formula ##STR1## wherein R is (CH.sub.2).sub.y CH.sub.3 or H, R' is CH.sub.2 or C(H) (CH.sub.2).sub.y CH.sub.3, and R" is CH.sub.2 or C(H) (CH.sub.2).sub.y CH.sub.3, with y ranging from 0 to 5, and x is 0 or 1 and wherein none or only one of R, R' and R" provides an alkyl substituent on ornithine or lysine moiety, and wherein Q is a heme binding moiety and/or a sulfur-containing binding moiety and Q' is --NH.sub.2 when there is a double bond between the omega carbon and Q and Q' is .dbd.NH when there is a single bond between the omega carbon and Q, and physiologically acceptable acid addition salts thereof.

REFERENCES:
patent: 3637837 (1972-01-01), Fujimoto et al.
patent: 3798269 (1974-03-01), Cutler et al.
patent: 4438204 (1984-03-01), Deeg et al.
patent: 4568640 (1986-02-01), Rubin
patent: 5028627 (1991-07-01), Kilbourn
patent: 5059624 (1991-10-01), Monache et al.
patent: 5059712 (1991-10-01), Griffith
patent: 5115100 (1992-05-01), Wu et al.
patent: 5133866 (1992-07-01), Kauvar
patent: 5158883 (1992-10-01), Griffith
patent: 5196195 (1993-03-01), Griffith
patent: 5216025 (1993-06-01), Gross et al.
patent: 5246971 (1993-09-01), Williamson et al.
patent: 5266594 (1993-11-01), Dawson et al.
patent: 5281627 (1994-01-01), Griffith
patent: 5286739 (1994-02-01), Kilbourn et al.
patent: 5296466 (1994-03-01), Kilbourn et al.
Adnot et al, Loss of Endothelium-Dependent Relaxation During Chronic Hypoxic Pulmonary Hypertension, Biol. Nitric Oxide, Proc. Int. Meet 1991, vol. 1-32-4.
Keiichi et al, Effect of Systemic L-Arginine Administration on Hemodyamics and Nitric Oxide Release, Jpn. Heart J., 33(1), 41-8, 1992.
Bodanszky, M., et al, The Practice of Peptide Synthesis, Springer-Verlang, New York, 1984, pp. 48, 49, 153, 154.
Feldman, P. L., Tetrahedron Lett., 32, 875-878, 1991.
Rees, D. D., et al, Br. J. Pharmacol., 96, 418-424 (1989).
Gray, G. A., et al, Br. J. Pharmacol., 103, 1218-1224 (May 1991).
Aisaka, K., et al, Biochem. Biophys Res. Commun. 163, No. 2, 710-717 (Sep. 15, 1989).
Julou-Schaeffer, G., et al, Am. J. Physiol. 259, H1038-H1043, Oct. 1990.

Affiliated with

Also associated with

Rating

Heme binding compounds and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heme binding compounds and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heme binding compounds and use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1310438